NinePointTwo Capital’s Elanco Animal Health ELAN Stock Holding History

NinePointTwo Capital’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$403K	Hold	27,111	–	–	0.16%	61
2023 Q3	$304K	Buy	+27,111	New	+$315K	0.12%	46
2023 Q2	–	Sell	-27,965	Closed	-$262K	–	274
2023 Q1	$262K	Buy	+27,965	New	+$330K	0.1%	101

Other funds holding ELAN

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Shapiro Capital Management Atlanta, Georgia $1.6B AUM 13.27% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

NinePointTwo Capital's ELAN Position: Q4 2023 in Review

NinePointTwo Capital held its Elanco Animal Health (ELAN) position steady in Q4 2023 at 27,111 shares worth $403K. The position accounts for 0.16% of the portfolio, ranked #61.

NinePointTwo Capital first reported a position in ELAN in Q1 2023 and has held it in 3 quarters since. 354 funds tracked by Wall St. Rank hold ELAN as of Q4 2023.

NinePointTwo Capital held 27,111 shares of Elanco Animal Health worth $403K as of Q4 2023.
NinePointTwo Capital left its Elanco Animal Health share count unchanged in Q4 2023.
Elanco Animal Health made up 0.16% of NinePointTwo Capital's portfolio in Q4 2023, its #61 holding.
NinePointTwo Capital first reported a position in Elanco Animal Health in Q1 2023 and has held it in 3 quarters since.
354 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2023.

Based on NinePointTwo Capital's 13F filing for Q4 2023, filed 14 Feb 2024.